Newbridge Financial Services Group’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95K | Hold |
1,352
| – | – | ﹤0.01% | 943 |
|
|
2025
Q1 | $11.3K | Hold |
1,352
| – | – | ﹤0.01% | 655 |
|
|
2024
Q4 | $10.1K | Hold |
1,352
| – | – | ﹤0.01% | 737 |
|
|
2024
Q3 | $7.84K | Sell |
1,352
-5,421
| -80% | -$31.4K | ﹤0.01% | 458 |
|
|
2024
Q2 | $45K | Hold |
6,773
| – | – | 0.02% | 396 |
|
|
2024
Q1 | $88.4K | Sell |
6,773
-350
| -5% | -$4.57K | 0.04% | 308 |
|
|
2023
Q4 | $90.8K | Buy |
7,123
+3,567
| +100% | +$45.5K | 0.04% | 289 |
|
|
2023
Q3 | $46.6K | Buy |
3,556
+733
| +26% | +$9.61K | 0.02% | 425 |
|
|
2023
Q2 | $72.2K | Hold |
2,823
| – | – | 0.04% | 374 |
|
|
2023
Q1 | $71.1K | Buy |
2,823
+369
| +15% | +$9.3K | 0.04% | 384 |
|
|
2022
Q4 | $56.4K | Hold |
2,454
| – | – | 0.03% | 427 |
|
|
2022
Q3 | $54K | Buy |
2,454
+547
| +29% | +$12K | 0.03% | 436 |
|
|
2022
Q2 | $27K | Hold |
1,907
| – | – | 0.02% | 566 |
|
|
2022
Q1 | $36K | Sell |
1,907
-318
| -14% | -$6K | 0.02% | 562 |
|
|
2021
Q4 | $41K | Hold |
2,225
| – | – | 0.02% | 521 |
|
|
2021
Q3 | $60K | Buy |
2,225
+907
| +69% | +$24.5K | 0.04% | 365 |
|
|
2021
Q2 | $41K | Buy |
+1,318
| New | +$41K | 0.03% | 509 |
|